[Updated 12/12/17, 5:51 pm. See below.] Global automotive technology supplier Aptiv is planting a bigger flag in Boston.
Whether you think self-driving cars are the stuff of science fiction or a potentially paradigm-shifting new form of transportation, autonomous vehicles are coming—and the companies developing them are spending big money to make it happen.
A few years ago, industry analysts... Read more »
Sam Isaly, managing partner of OrbiMed Advisors, is stepping down from the company. OrbiMed, a leading healthcare investment firm founded by Isaly, made the announcement Thursday, two days after Stat published a report of sexual harassment allegations from former OrbiMed employees... Read more »
Sage Therapeutics disclosed another clinical trial victory this morning, sending shares of the Cambridge, MA, company to new highs. An experimental Sage drug for major depressive disorder (MDD), a psychiatric disease that affects millions of Americans, has succeeded in a Phase... Read more »
Want to take part in an interactive, constructive talk about what can be done, right now, to alter the course of the life sciences scene in New York? You’ve still got a shot.
Next Monday evening, Dec. 11, at the... Read more »
It’s time to catch up on the latest Boston-area tech headlines:
—People can now ride around Boston’s Seaport neighborhood in a self-driving vehicle, thanks to a pilot program launched this week by ride-hailing company Lyft and NuTonomy, the autonomous vehicle software... Read more »
Healthcare investment giant OrbiMed Advisors has been described as a workplace enveloped in a toxic culture of sexual harassment, according to an investigation by Stat released late Tuesday.
[Corrected, 12/11/17, 1 p.m. ET. See below.] On Monday we posted the first part of our look at what should be some of 2018’s most important clinical data, including trials for lung cancer, heart disease, melanoma, Alzheimer’s disease,... Read more »
They embrace the unfamiliar, overcome adversity, and through it all, make the most of limited resources. These characteristics describe many entrepreneurs. But they also describe immigrants, says Noubar Afeyan, CEO of Cambridge, MA, venture capital firm Flagship Pioneering.
It’s no coincidence... Read more »
Author, investor, and AOL co-founder Steve Case today announced a new $150 million venture fund aimed at pumping investment capital into tech companies in so-called flyover states. Contributing to the fund is an impressive group of some of the most successful... Read more »
Registration is closing soon for Xconomy’s “What’s Hot in Cybersecurity” conference. It’s all happening tomorrow, December 5, at the WGBH offices in Brighton, MA.
We have lined up some of the most forward-thinking entrepreneurs, executives, investors, and innovators in cybersecurity. Join... Read more »
Online threats are mounting, and so are the investments in Boston-area cybersecurity companies. ReversingLabs is one of the latest to raise money—a $25 million Series A round announced Wednesday, led by Trident Capital Cybersecurity and JPMorgan Chase.
Cambridge, MA-based ReversingLabs’ software... Read more »
Member, NASA Technology Roadmap Review Steering Committee
Managing Dir. of Life Sciences, Hercules Technology Growth Capital
Professor, MIT Sloan School of Management
President Emeritus, MIT
Professor of Genetics, Harvard Medical School
Managing Director, Martin Trust Center for MIT Entrepreneurship
Co-founder, Chairman, and CEO, Flex Pharma
Co-Founder and Director, Boston Scientific Corporation
Founder and Managing Director, Lead Dog Ventures
CEO and President, Carbonite
Professor of Leadership, Emeritus at the Harvard Business School